Global Medical REIT (NYSE: GMRE) is one of 23 publicly-traded companies in the “Healthcare REITs” industry, but how does it weigh in compared to its rivals? We will compare Global Medical REIT to similar companies based on the strength of its institutional ownership, earnings, analyst recommendations, valuation, risk, dividends and profitability.
Insider and Institutional Ownership
41.0% of Global Medical REIT shares are owned by institutional investors. Comparatively, 82.7% of shares of all “Healthcare REITs” companies are owned by institutional investors. 16.5% of Global Medical REIT shares are owned by company insiders. Comparatively, 6.2% of shares of all “Healthcare REITs” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This table compares Global Medical REIT and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Global Medical REIT||-19.98%||-2.86%||-1.39%|
|Global Medical REIT Competitors||35.60%||7.69%||3.77%|
Global Medical REIT pays an annual dividend of $0.80 per share and has a dividend yield of 9.7%. Global Medical REIT pays out -296.3% of its earnings in the form of a dividend. As a group, “Healthcare REITs” companies pay a dividend yield of 5.5% and pay out 134.3% of their earnings in the form of a dividend. Global Medical REIT is clearly a better dividend stock than its rivals, given its higher yield and lower payout ratio.
Volatility and Risk
Global Medical REIT has a beta of -0.18, suggesting that its share price is 118% less volatile than the S&P 500. Comparatively, Global Medical REIT’s rivals have a beta of 0.33, suggesting that their average share price is 67% less volatile than the S&P 500.
Valuation & Earnings
This table compares Global Medical REIT and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Global Medical REIT||$8.21 million||-$6.35 million||-30.56|
|Global Medical REIT Competitors||$812.10 million||$208.81 million||184.80|
Global Medical REIT’s rivals have higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a summary of recent ratings and target prices for Global Medical REIT and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Global Medical REIT||0||1||5||0||2.83|
|Global Medical REIT Competitors||143||758||682||12||2.35|
Global Medical REIT currently has a consensus price target of $10.75, indicating a potential upside of 30.30%. As a group, “Healthcare REITs” companies have a potential upside of 7.12%. Given Global Medical REIT’s stronger consensus rating and higher possible upside, analysts clearly believe Global Medical REIT is more favorable than its rivals.
Global Medical REIT rivals beat Global Medical REIT on 9 of the 15 factors compared.
About Global Medical REIT
Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.